Prosecution Insights
Prosecution Insights
23 pending office actions • 13 clients • 22 examiners • 19 art units • 0 of 23 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 23 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 23 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 11 (48%) |
| §102 only | 5 (22%) |
| No statute on record | 7 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COFFA, SERGIO | 2 | 61.0% | +33.3% |
| BUI, PHUONG T | 1 | 81.6% | +22.8% |
| VALENROD, YEVGENY | 1 | 72.6% | +25.4% |
| BERTOGLIO, VALARIE E | 1 | 64.2% | +29.6% |
| DUCKWORTH, BRADLEY | 1 | 72.3% | +19.9% |
| RAO, PADMAJA S | 1 | 69.5% | +35.9% |
| GANGLE, BRIAN J | 1 | 76.4% | +15.4% |
| MORGAN, BAILEY MICHELLE | 1 | 57.1% | +56.3% |
| KETCHAM, KAREN A | 1 | 19.6% | +36.1% |
| LANDSMAN, ROBERT S | 1 | 81.3% | +12.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | LANDSMAN, ROBERT S | 24d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18307253 | TOPICAL FORMULATIONS | KETCHAM, KAREN A | 139d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18404084 | METHODS FOR IMPROVING AGRONOMIC TRAITS OF A PLANT | BUI, PHUONG T | 175d overdue |
| 18500470 | MOBILE DEVICE MOUNTING SYSTEM | DUCKWORTH, BRADLEY | 147d overdue |
| 18307253 | TOPICAL FORMULATIONS | KETCHAM, KAREN A | 139d overdue |
| 18633283 | N-Terminal Capping Modules of Ankyrin Repeat Domains | COFFA, SERGIO | 86d overdue |
| 18502249 | COMPOSITIONS AND METHODS FOR PRODUCING NON-HUMAN TISSUE ENGINEERED MEAT PRODUCTS | BERTOGLIO, VALARIE E | 85d overdue |
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | LANDSMAN, ROBERT S | 24d overdue |
| 18541691 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS | VALENROD, YEVGENY | 11d overdue |
| 18280531 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA | RAO, PADMAJA S | 12d |
| Client (Assignee) | Pending OAs |
|---|---|
| ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 7 |
| University of Illinois | 4 |
| University of Hawaii | 2 |
| Athebio AG | 1 |
| MYOS | 1 |
| PEAK DESIGN | 1 |
| University of Arizona | 1 |
| Pai Life Sciences Inc. | 1 |
| ProVEDA Corporation | 1 |
| WASHINGTON UNIVERSITY | 1 |
| RXCELL INC. | 1 |
| ORTIV-Q3 RESEARCH PVT. LTD | 1 |
| Novartis | 1 |
| Art Unit | Apps |
|---|---|
| 1633 | 3 |
| 1658 | 2 |
| 1645 | 2 |
| 1663 | 1 |
| 1628 | 1 |
| 1632 | 1 |
| 3632 | 1 |
| 1627 | 1 |
| 1614 | 1 |
| 1647 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18633283 | N-Terminal Capping Modules of Ankyrin Repeat Domains | Athebio AG | COFFA, SERGIO | 1658 | Other | Non-Final OA | 86d overdue | Pending | Apr 11, 2024 |
| 18404084 | METHODS FOR IMPROVING AGRONOMIC TRAITS OF A PLANT | The Board Of Trustees Of The University Of Illinois | BUI, PHUONG T | 1663 | — | Non-Final OA | 175d overdue | Pending | Jan 04, 2024 |
| 18541691 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS | St. Jude Children's Research Hospital | VALENROD, YEVGENY | 1628 | Other | Non-Final OA | 11d overdue | Pending | Dec 15, 2023 |
| 18502249 | COMPOSITIONS AND METHODS FOR PRODUCING NON-HUMAN TISSUE ENGINEERED MEAT PRODUCTS | Myos Corp. | BERTOGLIO, VALARIE E | 1632 | §103 | Non-Final OA | 85d overdue | Pending | Nov 06, 2023 |
| 18500470 | MOBILE DEVICE MOUNTING SYSTEM | Peak Design | DUCKWORTH, BRADLEY | 3632 | §103 | Final Rejection | 147d overdue | Pending | Nov 02, 2023 |
| 18280531 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA | Arizona Board of Regents | RAO, PADMAJA S | 1627 | §102 | Non-Final OA | 12d | Pending | Sep 06, 2023 |
| 18275463 | VACCINE AND METHODS FOR PREVENTING FILARIASIS AND DIROFILARIASIS | Pai Life Sciences Inc. | GANGLE, BRIAN J | 1645 | §102 | Non-Final OA | 48d | Pending | Aug 02, 2023 |
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | UNIVERSITY OF HAWAII | MORGAN, BAILEY MICHELLE | 1645 | §102 | Non-Final OA | 14d | Pending | Jun 16, 2023 |
| 18307253 | TOPICAL FORMULATIONS | Proveda Corporation | KETCHAM, KAREN A | 1614 | §103 | Non-Final OA | 139d overdue | Pending | Apr 26, 2023 |
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | St. Jude Children's Research Hospital | LANDSMAN, ROBERT S | 1647 | §102 | Non-Final OA | 24d overdue | Pending | Mar 14, 2023 |
| 18178736 | METHODS AND MICROFLUIDIC DEVICE FOR PRODUCING EXTRACELLULAR VESICLES | The Board Of Trustees Of The University Of Illinois | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Non-Final OA | 23d | Pending | Mar 06, 2023 |
| 18043136 | IN SITU CELL BIOREACTOR AND DELIVERY SYSTEM AND METHODS OF USING THE SAME | The Board Of Trustees Of The University Of Illinois | WHATLEY, BENJAMIN R | 1798 | §103 | Final Rejection | 8d | Pending | Feb 27, 2023 |
| 18042015 | COMPOSITIONS AND METHOD FOR TREATING THALASSEMIA | St. Jude Children's Research Hospital | WHITEMAN, BRIAN A | 1636 | §103 | Non-Final OA | 2d overdue | Pending | Feb 17, 2023 |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | St. Jude Children's Research Hospital | O'NEILL, MARISOL ANN | 1633 | §103 | Final Rejection | 9d | Pending | Feb 16, 2023 |
| 17927038 | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations | St. Jude Children's Research Hospital | PYLA, EVELYN Y | 1633 | §103 | Non-Final OA | 28d | Pending | Nov 22, 2022 |
| 17923029 | METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL INFECTION | Washington University | BELYAVSKYI, MICHAIL A | 1644 | §103 | Non-Final OA | 105d overdue | Pending | Nov 03, 2022 |
| 17923070 | Hypoimmunogenic Cells and Uses Thereof in Immune Responses | Rxcell Inc. | HUYNH, PHUONG N | 1641 | Other | Non-Final OA | 34d | Pending | Nov 03, 2022 |
| 17919622 | SYSTEM AND METHOD FOR MICRODIALYSIS FOR IN-VITRO RELEASE TESTING OF DOSAGE FORMS | Ortiv-Q3 Research Pvt. Ltd. | HERBERT, MADISON TAYLOR | 1758 | §103 | Non-Final OA | 34d | Pending | Oct 18, 2022 |
| 17778138 | PENTAPEPTIDE AND METHODS OF USE THEREOF | The Board Of Trustees Of The University Of Illinois | COFFA, SERGIO | 1658 | §102 | Non-Final OA | 28d | Pending | May 19, 2022 |
| 17777385 | METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY | Morphosys GmbH | MCCOLLUM, ANDREA K | 1674 | Other | Non-Final OA | 30d overdue | Pending | May 17, 2022 |
| 17774723 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | UNIVERSITY OF HAWAII | CHENG, KAREN | 1623 | §103 | Non-Final OA | 43d overdue | Pending | May 05, 2022 |
| 17550051 | Use of FOXP3 Enhancers to Modulate Regulatory T Cells | St. Jude Children's Research Hospital | WILSON, MICHAEL C | 1638 | — | Final Rejection | 2d overdue | Pending | Dec 14, 2021 |
| 17616279 | KIT AND METHOD FOR ANALYZING SINGLE T CELLS | St. Jude Children's Research Hospital | TURPIN, ZACHARY MARK | 1682 | Other | Non-Final OA | 225d overdue | Pending | Dec 03, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial